Please try another search
WESTLAKE VILLAGE, Calif. - Arcutis Biotherapeutics, Inc. (NASDAQ: NASDAQ:ARQT), a company specializing in immuno-dermatology, announced today the appointment of David Topper as its...
WESTLAKE VILLAGE, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on...
Arcutis Biotherapeutics (NASDAQ:ARQT), Inc. (Nasdaq: ARQT), a commercial-stage company focused on developing meaningful innovations in immuno-dermatology, today announced that...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Bullish doji Star | 15 | 1 | Apr 23, 2024 21:30 | ||
Falling Three Methods | 1D | 3 | Apr 18, 2024 | ||
Engulfing Bearish | 1H | 4 | Apr 23, 2024 17:00 | ||
Three Black Crows | 1W | 5 | Mar 17, 2024 | ||
Three Outside Down | 5H | 6 | Apr 18, 2024 18:00 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Access Holdings | 16.70 | 16.70 | 16.70 | +0.65 | +4.05% | 617.11K | |||
MTN Nigeria | 201.60 | 201.60 | 201.60 | 0.00 | 0.00% | 11.16K | |||
Lafarge Africa | 36.00 | 36.00 | 36.00 | 0.00 | 0.00% | 27.44K | |||
Guaranty Trust Holding | 36.00 | 36.00 | 36.00 | +0.25 | +0.70% | 50.37K | |||
UBA | 23.20 | 23.20 | 23.20 | +0.20 | +0.87% | 149.04K | |||
Fcmb | 7.150 | 7.150 | 7.150 | +0.650 | +10.00% | 28.97K | 10:17:00 | ||
Transcorp | 14.000 | 14.700 | 14.000 | -0.900 | -6.04% | 1.65M | 10:20:00 | ||
Zenith Bank | 37.00 | 37.50 | 37.00 | +1.00 | +2.78% | 1.66M | 10:18:00 | ||
Nestle Nigeria | 880.00 | 880.00 | 880.00 | +60.00 | +7.32% | 0.52K | |||
Vitafoam Nig | 18.70 | 18.70 | 18.70 | +1.55 | +9.04% | 32.43K | 10:12:00 |
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review